	From Clinical Reality to Blueprint Designing: A Qualitative Study Exploring Communication Challenges and Unmet Needs for Patient Decision Aid Development in Early-Stage Breast Cancer. Psychooncology Sdinami S, Maialetti M, Sebri V, Zagami P, Grasso R, Curigliano G, Pravettoni G. PMID: 42831611 [PubMed - indexed for MEDLINE]
	Histopathological and Bioinformatic Analysis of the IL-6/STAT3 Signaling Pathway in Ovarian Neoplasms. Pak J Biol Sci Anika UL, Hellyanti T, Mahendra FR, Kodariah R. PMID: 42831402 [PubMed - indexed for MEDLINE]
	Redefining breast cancer treatment by precision oncology: the clinical impact of sacituzumab govitecan. Expert Opin Biol Ther Di Lauro V, Sacco PC, Palma V, von Arx C, Buono G, Caputo R, Piezzo M, Cocco S, Vitale E, Santoni M, Gridelli C, De Laurentiis M, Massafra R, Ciccimarra F, Rizzo A. PMID: 42831394 [PubMed - as supplied by publisher]
	Gedatolisib for the treatment of hormone receptor-positive/HER2-negative advanced breast cancer: a European perspective. Future Oncol Matera L, Etessami JD, Valenza C, Curigliano G. PMID: 42831391 [PubMed - as supplied by publisher]
	Advances in 3D Bioprinting for Breast Cancer Modeling: Tumor Microenvironment, Metastasis, and Drug Screening. Adv Healthc Mater Nakipoglu M, Mahmoodi M, Apu EH, Shahabipour F, Emir Diltemiz S, Saha S, Alem H, Ashammakhi N. PMID: 42831290 [PubMed - as supplied by publisher]
	Multi-omics studies identified the molecular network of mitochondrial dysfunction in the pathogenesis of breast cancer. Genes Dis Liu J, Guan X, Quan L, Dou M, Yuan P. PMID: 42831172 [PubMed]
	The influence of virtual reality on anxiety and pain in breast cancer patients: A systematic review. Tech Innov Patient Support Radiat Oncol Kundarti FI, Triwiyanto T, Titisari I, Sujianto U, Nurlaili A, Azmi ZF. PMID: 42831052 [PubMed]
	Chest wall pain as a late effect following radiotherapy for breast cancer: A systematic review of prevalence and risk factors. Tech Innov Patient Support Radiat Oncol Durrant L, Harris R, Atkinson C, Faithfull S. PMID: 42830996 [PubMed]
	VEGF-Leptin Crosstalk in Breast and Ovarian Cancer: Drivers of Angiogenesis and Progression. Cancer Manag Res Al-Eidan AA. PMID: 42830884 [PubMed]
	Real-world outcomes in patients with advanced epithelial ovarian cancer receiving niraparib as first-line maintenance: a European retrospective cohort study. ESMO Real World Data Digit Oncol Fagotti A, Frenel JS, Saint-Ghislain M, Lim JT, Calderón Boyle TA, Golembesky AK, Hogg C, Arnold K, Braicu EI. PMID: 42830865 [PubMed]
	Integrative Multiomics Profiling Reveals Immune Determinants of Response to Disitamab Vedotin Plus Penpulimab in HER2-Low Breast Cancer. MedComm (2020) Liu X, Song Y, Liu L, Zhang AQ, Xie X, Wei B, He P, Zhuang C, Li J, Yan X, Tian T, Zhong X, Chen J, Cheng Y, Zheng D, Li S, Wang H, Luo T. PMID: 42830862 [PubMed]
	HER2-Targeted Antibody-Drug Conjugates in Advanced HER2-Low Breast Cancer: Mechanisms, Clinical Efficacy, and Resistance Strategies. Cancer Manag Res Yang M, Ding X, Ye P, Xu X. PMID: 42830854 [PubMed]
	Impact of Human Papillomavirus Primary Cervical Screening on Referral Rates and Outcomes for People Referred to Colposcopy for Clinical Reasons. Aust N Z J Obstet Gynaecol Khan A, Gullery K, Barber G, Ormandy J. PMID: 42830662 [PubMed - indexed for MEDLINE]
	Differential diagnostic value of PAX1 and JAM3 methylation for cervical intraepithelial neoplasia between premenopausal and postmenopausal women: a retrospective clinical study in China. Ann Med Wang P, Zhang M, Lai Y, Song T, Shen Y, Chen H, Chen X. PMID: 42830604 [PubMed - indexed for MEDLINE]
	Interobserver Reproducibility of Treatment-Defining HER2-Low and HER2-Ultralow Immunohistochemical Scoring in Breast Carcinoma: A Systematic Review. Appl Immunohistochem Mol Morphol Tayade V, Singh G. PMID: 42830597 [PubMed - as supplied by publisher]
	Microscopic hyperspectral discrimination of triple-negative and HER2-positive breast cancer in routine hematoxylin-eosin sections. Photodiagnosis Photodyn Ther Meng F, Yan J, Shi G, Li J. PMID: 42830153 [PubMed - as supplied by publisher]
	PD-L1 EXPRESSION AND SERUM CA125: CLINICOPATHOLOGICAL CORRELATIONS IN HIGH-GRADE SEROUS OVARIAN CARCINOMA. Georgian Med News Kosayeva T, Amiraslanov A, Muradov H, Gaziyev A, Abbasov B. PMID: 42830063 [PubMed - indexed for MEDLINE]
	BRIDGING THE COVERAGE-PARTICIPATION GAP: BEHAVIORAL DETERMINANTS OF CERVICAL CANCER SCREENING AMONG WOMEN IN ADJARA, GEORGIA. Georgian Med News Kamashidze K, Beruchashvili T, Nakashidze I, Ahmad S, Peshkova T. PMID: 42830062 [PubMed - indexed for MEDLINE]
	Development and Validation of a Predictive Model for Subclinical Myocardial Dysfunction in Breast Cancer Patients Receiving Doxorubicin-Based Chemotherapy: Integrating 2D Speckle Tracking Echocardiography and Conventional Echocardiographic Parameters. Echocardiography Wang S, Wang B, Liu Q, Jiang J, Chen M, Wu F, Bao J. PMID: 42829946 [PubMed - indexed for MEDLINE]
	Dual-targeted nanotechnology for gynaecological cancers: a comprehensive review of mechanisms and clinical potential. Ann Med Tu X, Zhang Y, Wang L, Shan Y, Xie L, Shou H, Liang Y. PMID: 42829857 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 336066

Page 1 of 16804



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy